Literature DB >> 23938125

Correlation between corneal and scleral pneumatonometry: an alternative method for intraocular pressure measurement.

Michael A Kapamajian1, Jose de la Cruz, Joelle A Hallak, Thasarat S Vajaranant.   

Abstract

PURPOSE: To evaluate scleral pneumatonometry as an alternative method for measuring intraocular pressure (IOP).
DESIGN: Prospective cross-sectional study.
METHODS: Adult subjects with healthy eyes were recruited from the Comprehensive Eye Service at the University of Illinois Eye and Ear Infirmary from August 2008 through February 2009. Study measurements included corneal pneumatonometry (IOPk), scleral pneumatonometry (IOPs), axial length (AL), spherical equivalent (SE), and central corneal thickness (CCT). Main outcome measures were scleral IOP and corneal IOP.
RESULTS: Analysis included a monocular data set from single eyes of 97 subjects (age: 18-82 years). IOPs was consistently higher than IOPk, and correlated positively with IOPk (r = 0.57, P < .0001), age (r = 0.51, P < .0001), and SE (r = 0.32, P = .0002). The difference between scleral and corneal IOP (IOPs - IOPk) correlated positively with IOPs (r = 0.89, P < .0001), age (r = 0.57, P < .0001), and SE (r = 0.34, P < 0.0001). Bland-Altman analysis for agreement between scleral and corneal pneumatonometry measurements showed a mean difference of 8.08 mm Hg, with the 95% limit of agreement between -3.47 and 19.64 mm Hg. Regression analysis yielded the following equation: IOPk = 11.9 + 0.32(IOPs) - 0.05(Age).
CONCLUSIONS: Scleral pneumatonometry correlates positively with corneal pneumatonometry and is more accurate at lower values and in younger patients. When adjusted for age, scleral pneumatonometry may be an adequate alternative in situations where corneal measurements are impractical.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23938125     DOI: 10.1016/j.ajo.2013.05.045

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Limbal rebound tonometry: clinical comparisons and applications.

Authors:  Georgios Bontzos; Michail Agiorgiotakis; Zoi Kapsala; Efstathios Detorakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-28       Impact factor: 3.117

2.  Innovative approaches to glaucoma management of Boston keratoprosthesis type 1.

Authors:  Thasarat S Vajaranant; Jessica Liu; Jacob Wilensky; M Soledad Cortina; Ahmad A Aref
Journal:  Curr Ophthalmol Rep       Date:  2016-07-26

3.  Intraocular Pressure After 2 Hours of Small-Diameter Scleral Lens Wear.

Authors:  Cherie B Nau; Muriel M Schornack; Jay W McLaren; Arthur J Sit
Journal:  Eye Contact Lens       Date:  2016-11       Impact factor: 2.018

4.  Correlation of Serial Scleral and Corneal Pneumatonometry.

Authors:  Debbie S Kuo; Yvonne Ou; Bennie H Jeng; Robert Bhisitkul; Jay M Stewart; Jacque L Duncan; Ying Han
Journal:  Ophthalmology       Date:  2015-07-10       Impact factor: 12.079

5.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

6.  Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.

Authors:  Mohsin H Ali; Mark S Dikopf; Anthony G Finder; Ahmad A Aref; Thasarat Vajaranant; Jose de la Cruz; Maria Soledad Cortina
Journal:  Cornea       Date:  2018-05       Impact factor: 2.651

7.  Comparison of Pneumatonometry and Transpalpebral Tonometry Measurements of Intraocular Pressure during Scleral Lens Wear.

Authors:  Jennifer Swingle Fogt; Cherie B Nau; Muriel Schornack; Ellen Shorter; Amy Nau; Jennifer S Harthan
Journal:  Optom Vis Sci       Date:  2020-09       Impact factor: 2.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.